Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 40 entries
Sorted by: Best Match Show Resources per page
Primary sclerosing cholangitis: a new cause of distal renal tubular acidosis.

Clinical kidney journal

Goutaudier V, Szwarc I, Serre JE, Pageaux GP, Argilés À, Ribstein J.
PMID: 27994859
Clin Kidney J. 2016 Dec;9(6):811-813. doi: 10.1093/ckj/sfw085. Epub 2016 Aug 31.

We describe the first case of distal renal tubular acidosis (dRTA) associated with primary sclerosing cholangitis. A 26-year-old Lao-Thai male patient presented with severe jaundice, metabolic acidosis and hypokalaemia. He was diagnosed of dRTA. Liver transplantation resulted in correction...

Cite
Goutaudier V, Szwarc I, Serre JE, et al. Primary sclerosing cholangitis: a new cause of distal renal tubular acidosis. Clin Kidney J. 2016;9(6):811-813doi: 10.1093/ckj/sfw085.
Goutaudier, V., Szwarc, I., Serre, J. E., Pageaux, G. P., Argilés, �. �., & Ribstein, J. (2016). Primary sclerosing cholangitis: a new cause of distal renal tubular acidosis. Clinical kidney journal, 9(6), 811-813. https://doi.org/10.1093/ckj/sfw085
Goutaudier, Valentin, et al. "Primary sclerosing cholangitis: a new cause of distal renal tubular acidosis." Clinical kidney journal vol. 9,6 (2016): 811-813. doi: https://doi.org/10.1093/ckj/sfw085
Goutaudier V, Szwarc I, Serre JE, Pageaux GP, Argilés À, Ribstein J. Primary sclerosing cholangitis: a new cause of distal renal tubular acidosis. Clin Kidney J. 2016 Dec;9(6):811-813. doi: 10.1093/ckj/sfw085. Epub 2016 Aug 31. PMID: 27994859; PMCID: PMC5162411.
Copy Download .nbib Format: NLM
Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based Therapy.

Mediterranean journal of hematology and infectious diseases

Nguyen TT, Niloofar R, Rubbo PA, Nils K, Bollore K, Ducos J, Pageaux GP, Reynes J, Van de Perre P, Tuaillon E.
PMID: 26740864
Mediterr J Hematol Infect Dis. 2016 Jan 01;8(1):e2016003. doi: 10.4084/MJHID.2016.003. eCollection 2016.

BACKGROUND: Treatment of hepatitis C virus (HCV) infection based on peginterferon-α (pegIFNα) and ribavirin induces important changes in cytokine release and T cell activation.OBJECTIVE: Immune response to pegIFNα-ribavirin therapy was explored in patients coinfected by HCV and HIV.METHODS: Concentrations...

Cite
Nguyen TT, Niloofar R, Rubbo PA, et al. Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based Therapy. Mediterr J Hematol Infect Dis. 2016;8(1):e2016003doi: 10.4084/MJHID.2016.003.
Nguyen, T. T., Niloofar, R., Rubbo, P. A., Nils, K., Bollore, K., Ducos, J., Pageaux, G. P., Reynes, J., Van de Perre, P., & Tuaillon, E. (2016). Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based Therapy. Mediterranean journal of hematology and infectious diseases, 8(1), e2016003. https://doi.org/10.4084/MJHID.2016.003
Nguyen, Truong Tam, et al. "Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based Therapy." Mediterranean journal of hematology and infectious diseases vol. 8,1 (2016): e2016003. doi: https://doi.org/10.4084/MJHID.2016.003
Nguyen TT, Niloofar R, Rubbo PA, Nils K, Bollore K, Ducos J, Pageaux GP, Reynes J, Van de Perre P, Tuaillon E. Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based Therapy. Mediterr J Hematol Infect Dis. 2016 Jan 01;8(1):e2016003. doi: 10.4084/MJHID.2016.003. eCollection 2016. PMID: 26740864; PMCID: PMC4696469.
Copy Download .nbib Format: NLM
Fatigue Induced by Physical and Mental Exertion Increases Perception of Effort and Impairs Subsequent Endurance Performance.

Frontiers in physiology

Pageaux B, Lepers R.
PMID: 27965592
Front Physiol. 2016 Nov 29;7:587. doi: 10.3389/fphys.2016.00587. eCollection 2016.

Endurance performance involves the prolonged maintenance of constant or self-regulated power/velocity or torque/force. While the impact of numerous determinants of endurance performance has been previously reviewed, the impact of fatigue on subsequent endurance performance still needs to be documented....

Cite
Pageaux B, Lepers R. Fatigue Induced by Physical and Mental Exertion Increases Perception of Effort and Impairs Subsequent Endurance Performance. Front Physiol. 2016;7:587doi: 10.3389/fphys.2016.00587.
Pageaux, B., & Lepers, R. (2016). Fatigue Induced by Physical and Mental Exertion Increases Perception of Effort and Impairs Subsequent Endurance Performance. Frontiers in physiology, 7587. https://doi.org/10.3389/fphys.2016.00587
Pageaux, Benjamin, and Lepers, Romuald. "Fatigue Induced by Physical and Mental Exertion Increases Perception of Effort and Impairs Subsequent Endurance Performance." Frontiers in physiology vol. 7 (2016): 587. doi: https://doi.org/10.3389/fphys.2016.00587
Pageaux B, Lepers R. Fatigue Induced by Physical and Mental Exertion Increases Perception of Effort and Impairs Subsequent Endurance Performance. Front Physiol. 2016 Nov 29;7:587. doi: 10.3389/fphys.2016.00587. eCollection 2016. PMID: 27965592; PMCID: PMC5126404.
Copy Download .nbib Format: NLM
Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors.

European journal of applied physiology

Angius L, Pageaux B, Crisafulli A, Hopker J, Marcora SM.
PMID: 34596759
Eur J Appl Physiol. 2022 Jan;122(1):141-155. doi: 10.1007/s00421-021-04815-0. Epub 2021 Oct 01.

PURPOSE: This study investigated the effect of ischemic preconditioning (IP) on metaboreflex activation following dynamic leg extension exercise in a group of healthy participants.METHOD: Seventeen healthy participants were recruited. IP and SHAM treatments (3 × 5 min cuff occlusion...

Cite
Angius L, Pageaux B, Crisafulli A, et al. Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors. Eur J Appl Physiol. 2021;122(1):141-155doi: 10.1007/s00421-021-04815-0.
Angius, L., Pageaux, B., Crisafulli, A., Hopker, J., & Marcora, S. M. (2022). Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors. European journal of applied physiology, 122(1), 141-155. https://doi.org/10.1007/s00421-021-04815-0
Angius, Luca, et al. "Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors." European journal of applied physiology vol. 122,1 (2022): 141-155. doi: https://doi.org/10.1007/s00421-021-04815-0
Angius L, Pageaux B, Crisafulli A, Hopker J, Marcora SM. Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors. Eur J Appl Physiol. 2022 Jan;122(1):141-155. doi: 10.1007/s00421-021-04815-0. Epub 2021 Oct 01. PMID: 34596759.
Copy Download .nbib Format: NLM
Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors.

European journal of applied physiology

Angius L, Pageaux B, Crisafulli A, Hopker J, Marcora SM.
PMID: 34596759
Eur J Appl Physiol. 2021 Oct 01; doi: 10.1007/s00421-021-04815-0. Epub 2021 Oct 01.

PURPOSE: This study investigated the effect of ischemic preconditioning (IP) on metaboreflex activation following dynamic leg extension exercise in a group of healthy participants.METHOD: Seventeen healthy participants were recruited. IP and SHAM treatments (3 × 5 min cuff occlusion...

Cite
Angius L, Pageaux B, Crisafulli A, et al. Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors. Eur J Appl Physiol. 2021;doi: 10.1007/s00421-021-04815-0.
Angius, L., Pageaux, B., Crisafulli, A., Hopker, J., & Marcora, S. M. (2021). Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors. European journal of applied physiology, . https://doi.org/10.1007/s00421-021-04815-0
Angius, Luca, et al. "Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors." European journal of applied physiology vol. (2021). doi: https://doi.org/10.1007/s00421-021-04815-0
Angius L, Pageaux B, Crisafulli A, Hopker J, Marcora SM. Ischemic preconditioning of the muscle reduces the metaboreflex response of the knee extensors. Eur J Appl Physiol. 2021 Oct 01; doi: 10.1007/s00421-021-04815-0. Epub 2021 Oct 01. PMID: 34596759.
Copy Download .nbib Format: NLM
Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation.

Hepatology communications

Hermida M, Preel A, Assenat E, Piron L, Cassinotto C, Ursic-Bedoya J, Guillot C, Herrero A, Panaro F, Pageaux GP, Guiu B.
PMID: 33860126
Hepatol Commun. 2020 Dec 31;5(4):689-700. doi: 10.1002/hep4.1661. eCollection 2021 Apr.

Percutaneous thermal ablation is a validated treatment option for small hepatocellular carcinoma (HCC). Steatotic HCC can be reliably detected by magnetic resonance imaging. To determine the clinical relevance of this radiological variant, we included 235 patients (cirrhosis in 92.3%,...

Cite
Hermida M, Preel A, Assenat E, et al. Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation. Hepatol Commun. 2020;5(4):689-700doi: 10.1002/hep4.1661.
Hermida, M., Preel, A., Assenat, E., Piron, L., Cassinotto, C., Ursic-Bedoya, J., Guillot, C., Herrero, A., Panaro, F., Pageaux, G. P., & Guiu, B. (2021). Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation. Hepatology communications, 5(4), 689-700. https://doi.org/10.1002/hep4.1661
Hermida, Margaux, et al. "Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation." Hepatology communications vol. 5,4 (2021): 689-700. doi: https://doi.org/10.1002/hep4.1661
Hermida M, Preel A, Assenat E, Piron L, Cassinotto C, Ursic-Bedoya J, Guillot C, Herrero A, Panaro F, Pageaux GP, Guiu B. Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation. Hepatol Commun. 2020 Dec 31;5(4):689-700. doi: 10.1002/hep4.1661. eCollection 2021 Apr. PMID: 33860126; PMCID: PMC8034567.
Copy Download .nbib Format: NLM
Challenges in providing ethically competent health care to incarcerated older adults with mental illness: a qualitative study exploring mental health professionals' perspectives in Canada.

BMC geriatrics

Mussie KM, Pageau F, Merkt H, Wangmo T, Elger BS.
PMID: 34922493
BMC Geriatr. 2021 Dec 18;21(1):718. doi: 10.1186/s12877-021-02687-9.

BACKGROUND: The population of incarcerated older adults is the fastest growing demographic in prisons. Older persons in custody have poorer health as compared with those in the community. The unmet and complex health care needs of incarcerated older adults...

Cite
Mussie KM, Pageau F, Merkt H, et al. Challenges in providing ethically competent health care to incarcerated older adults with mental illness: a qualitative study exploring mental health professionals' perspectives in Canada. BMC Geriatr. 2021;21(1):718doi: 10.1186/s12877-021-02687-9.
Mussie, K. M., Pageau, F., Merkt, H., Wangmo, T., & Elger, B. S. (2021). Challenges in providing ethically competent health care to incarcerated older adults with mental illness: a qualitative study exploring mental health professionals' perspectives in Canada. BMC geriatrics, 21(1), 718. https://doi.org/10.1186/s12877-021-02687-9
Mussie, Kirubel Manyazewal, et al. "Challenges in providing ethically competent health care to incarcerated older adults with mental illness: a qualitative study exploring mental health professionals' perspectives in Canada." BMC geriatrics vol. 21,1 (2021): 718. doi: https://doi.org/10.1186/s12877-021-02687-9
Mussie KM, Pageau F, Merkt H, Wangmo T, Elger BS. Challenges in providing ethically competent health care to incarcerated older adults with mental illness: a qualitative study exploring mental health professionals' perspectives in Canada. BMC Geriatr. 2021 Dec 18;21(1):718. doi: 10.1186/s12877-021-02687-9. PMID: 34922493.
Copy Download .nbib Format: NLM
Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma.

Cancers

Cantaloube M, Castan F, Creoff M, Prunaretty J, Bordeau K, Michalet M, Assenat E, Guiu B, Pageaux GP, Ychou M, Aillères N, Fenoglietto P, Azria D, Riou O.
PMID: 34638336
Cancers (Basel). 2021 Sep 28;13(19). doi: 10.3390/cancers13194853.

Liver SBRT is a therapeutic option for the treatment of HCC in patients not eligible for other local therapies. We retrospectively report the outcomes of a cohort of consecutive patients treated with SBRT for HCC at the Montpellier Cancer...

Cite
Cantaloube M, Castan F, Creoff M, et al. Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma. Cancers (Basel). 2021;13(19)doi: 10.3390/cancers13194853.
Cantaloube, M., Castan, F., Creoff, M., Prunaretty, J., Bordeau, K., Michalet, M., Assenat, E., Guiu, B., Pageaux, G. P., Ychou, M., Aillères, N., Fenoglietto, P., Azria, D., & Riou, O. (2021). Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma. Cancers, 13(19), . https://doi.org/10.3390/cancers13194853
Cantaloube, Marie, et al. "Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma." Cancers vol. 13,19 (2021). doi: https://doi.org/10.3390/cancers13194853
Cantaloube M, Castan F, Creoff M, Prunaretty J, Bordeau K, Michalet M, Assenat E, Guiu B, Pageaux GP, Ychou M, Aillères N, Fenoglietto P, Azria D, Riou O. Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma. Cancers (Basel). 2021 Sep 28;13(19). doi: 10.3390/cancers13194853. PMID: 34638336; PMCID: PMC8507769.
Copy Download .nbib Format: NLM
Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model.

Cancers

Brusset B, Dumortier J, Cherqui D, Pageaux GP, Boleslawski E, Chapron L, Quesada JL, Radenne S, Samuel D, Navarro F, Dharancy S, Decaens T.
PMID: 34069594
Cancers (Basel). 2021 May 19;13(10). doi: 10.3390/cancers13102480.

PURPOSE: To compare the agreement for the criteria on the explant and the results of liver transplantation (LT) before and after adoption of the AFP (α-fetoprotein) model.METHODS: 523 patients consecutively listed in five French centers were reviewed to compare...

Cite
Brusset B, Dumortier J, Cherqui D, et al. Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model. Cancers (Basel). 2021;13(10)doi: 10.3390/cancers13102480.
Brusset, B., Dumortier, J., Cherqui, D., Pageaux, G. P., Boleslawski, E., Chapron, L., Quesada, J. L., Radenne, S., Samuel, D., Navarro, F., Dharancy, S., & Decaens, T. (2021). Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model. Cancers, 13(10), . https://doi.org/10.3390/cancers13102480
Brusset, Bleuenn, et al. "Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model." Cancers vol. 13,10 (2021). doi: https://doi.org/10.3390/cancers13102480
Brusset B, Dumortier J, Cherqui D, Pageaux GP, Boleslawski E, Chapron L, Quesada JL, Radenne S, Samuel D, Navarro F, Dharancy S, Decaens T. Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model. Cancers (Basel). 2021 May 19;13(10). doi: 10.3390/cancers13102480. PMID: 34069594; PMCID: PMC8160826.
Copy Download .nbib Format: NLM
Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV Patients.

Hepatology (Baltimore, Md.)

Meszaros M, Truchi R, Ouzan D, Tran A, Bourlière M, Pageaux GP.
PMID: 34008214
Hepatology. 2021 Oct;74(4):2304-2306. doi: 10.1002/hep.31909. Epub 2021 Jun 16.

No abstract available.

Cite
Meszaros M, Truchi R, Ouzan D, et al. Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV Patients. Hepatology. 2021;74(4):2304-2306doi: 10.1002/hep.31909.
Meszaros, M., Truchi, R., Ouzan, D., Tran, A., Bourlière, M., & Pageaux, G. P. (2021). Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV Patients. Hepatology (Baltimore, Md.), 74(4), 2304-2306. https://doi.org/10.1002/hep.31909
Meszaros, Magdalena, et al. "Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV Patients." Hepatology (Baltimore, Md.) vol. 74,4 (2021): 2304-2306. doi: https://doi.org/10.1002/hep.31909
Meszaros M, Truchi R, Ouzan D, Tran A, Bourlière M, Pageaux GP. Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV Patients. Hepatology. 2021 Oct;74(4):2304-2306. doi: 10.1002/hep.31909. Epub 2021 Jun 16. PMID: 34008214.
Copy Download .nbib Format: NLM
Combined Liver-Kidney Transplantation With Preformed Anti-human Leukocyte Antigen Donor-Specific Antibodies.

Kidney international reports

Del Bello A, Thaunat O, Le Quintrec M, Bestard O, Durrbach A, Perrin P, Gatault P, Jambon F, Pageaux GP, Llado L, Besch C, Barbier L, Neau-Cransac M, Dumortier J, Kamar N.
PMID: 33305113
Kidney Int Rep. 2020 Oct 03;5(12):2202-2211. doi: 10.1016/j.ekir.2020.09.018. eCollection 2020 Dec.

INTRODUCTION: The impact of preformed donor-specific anti-human leukocyte antigen (HLA) antibodies (pDSAs) after combined liver-kidney transplantation (CLKT) is still uncertain.METHODS: We conducted a retrospective study in 8 European high-volume transplant centers and investigated the outcome of 166 consecutive CLKTs,...

Cite
Del Bello A, Thaunat O, Le Quintrec M, et al. Combined Liver-Kidney Transplantation With Preformed Anti-human Leukocyte Antigen Donor-Specific Antibodies. Kidney Int Rep. 2020;5(12):2202-2211doi: 10.1016/j.ekir.2020.09.018.
Del Bello, A., Thaunat, O., Le Quintrec, M., Bestard, O., Durrbach, A., Perrin, P., Gatault, P., Jambon, F., Pageaux, G. P., Llado, L., Besch, C., Barbier, L., Neau-Cransac, M., Dumortier, J., & Kamar, N. (2020). Combined Liver-Kidney Transplantation With Preformed Anti-human Leukocyte Antigen Donor-Specific Antibodies. Kidney international reports, 5(12), 2202-2211. https://doi.org/10.1016/j.ekir.2020.09.018
Del Bello, Arnaud, et al. "Combined Liver-Kidney Transplantation With Preformed Anti-human Leukocyte Antigen Donor-Specific Antibodies." Kidney international reports vol. 5,12 (2020): 2202-2211. doi: https://doi.org/10.1016/j.ekir.2020.09.018
Del Bello A, Thaunat O, Le Quintrec M, Bestard O, Durrbach A, Perrin P, Gatault P, Jambon F, Pageaux GP, Llado L, Besch C, Barbier L, Neau-Cransac M, Dumortier J, Kamar N. Combined Liver-Kidney Transplantation With Preformed Anti-human Leukocyte Antigen Donor-Specific Antibodies. Kidney Int Rep. 2020 Oct 03;5(12):2202-2211. doi: 10.1016/j.ekir.2020.09.018. eCollection 2020 Dec. PMID: 33305113; PMCID: PMC7710847.
Copy Download .nbib Format: NLM
Liver transplantation for alcoholic liver disease.

Addiction biology

Pageaux GP, Perney P, Larrey D.
PMID: 11900608
Addict Biol. 2001 Sep;6(4):301-308. doi: 10.1080/13556210020077037.

Although increasing numbers of alcoholic patients are being referred to liver transplant centres, liver transplantation for alcoholic liver disease still remains controversial, essentially because we are in an era of organ shortage. In fact, the main issue is the...

Cite
Pageaux GP, Perney P, Larrey D. Liver transplantation for alcoholic liver disease. Addict Biol. 2001;6(4):301-308doi: 10.1080/13556210020077037.
Pageaux, G. P., Perney, P., & Larrey, D. (2001). Liver transplantation for alcoholic liver disease. Addiction biology, 6(4), 301-308. https://doi.org/10.1080/13556210020077037
Pageaux, Georges-Philippe, et al. "Liver transplantation for alcoholic liver disease." Addiction biology vol. 6,4 (2001): 301-308. doi: https://doi.org/10.1080/13556210020077037
Pageaux GP, Perney P, Larrey D. Liver transplantation for alcoholic liver disease. Addict Biol. 2001 Sep;6(4):301-308. doi: 10.1080/13556210020077037. PMID: 11900608.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 40 entries